CCM
BMY icon

Cinctive Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Cinctive Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,000
Closed -$3.85M – 474
2022
Q2 		$3.85M Buy
+50,000
New +$3.81M 0.16% 209

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cinctive Capital Management's BMY Position: Q2 2026 in Review

Cinctive Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 110,079 shares — an estimated $6.68M sold.

Cinctive Capital Management first reported a position in BMY in Q4 2019 and held it in 9 quarters. The position peaked at $16.5M in Q1 2021. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Cinctive Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 110,079 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.68M.
  • Cinctive Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 9 quarters.
  • Cinctive Capital Management's Bristol-Myers Squibb position peaked at $16.5M in Q1 2021.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.